These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12049679)

  • 21. Validation and clinical application of time-frequency analysis of atrial fibrillation electrocardiograms.
    Husser D; Stridh M; Cannom DS; Bhandari AK; Girsky MJ; Kang S; Sörnmo L; Bertil Olsson S; Bollmann A
    J Cardiovasc Electrophysiol; 2007 Jan; 18(1):41-6. PubMed ID: 17229299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide.
    Bollmann A; Kanuru NK; McTeague KK; Walter PF; DeLurgio DB; Langberg JJ
    Am J Cardiol; 1998 Jun; 81(12):1439-45. PubMed ID: 9645894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of verapamil and ibutilide on atrial fibrillation and postfibrillation atrial refractoriness.
    Sticherling C; Hsu W; Tada H; Bares AC; Oral H; Pelosi F; Knight BP; Strickberger SA; Morady F
    J Cardiovasc Electrophysiol; 2002 Feb; 13(2):151-7. PubMed ID: 11900290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decrease of the atrial fibrillatory rate, increased organization of the atrial rhythm and termination of atrial fibrillation by AZD7009.
    Aunes-Jansson M; Edvardsson N; Stridh M; Sörnmo L; Frison L; Berggren A
    J Electrocardiol; 2013; 46(1):29-35. PubMed ID: 23219385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency analysis of the fibrillatory activity from surface ECG lead V1 and intracardiac recordings: implications for mapping of AF.
    Hsu NW; Lin YJ; Tai CT; Kao T; Chang SL; Wongcharoen W; Lo LW; Udyavar AR; Hu YF; Tso HW; Chen YJ; Higa S; Chen SA
    Europace; 2008 Apr; 10(4):438-43. PubMed ID: 18319264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans.
    Daoud EG; Knight BP; Weiss R; Bahu M; Paladino W; Goyal R; Man KC; Strickberger SA; Morady F
    Circulation; 1997 Sep; 96(5):1542-50. PubMed ID: 9315545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface ECG f Wave Analysis at Initial Onset of Paroxysmal and Persistent Atrial Fibrillation.
    Sharma P; Barrett TW; Ng J; Knoten C; Ferreira AJ; Goldberger JJ
    J Cardiovasc Electrophysiol; 2017 May; 28(5):498-503. PubMed ID: 28190278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial electrophysiological effects of ibutilide infusion in humans.
    Schwartz RA; Langberg JJ
    Pacing Clin Electrophysiol; 2000 May; 23(5):832-6. PubMed ID: 10833702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profibrillatory effects of verapamil but not of digoxin in the goat model of atrial fibrillation.
    Duytschaever MF; Garratt CJ; Allessie MA
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1375-85. PubMed ID: 11196562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of left atrial diameter and atrial fibrillatory frequency for conversion of persistent atrial fibrillation with oral flecainide.
    Bollmann A; Binias KH; Toepffer I; Molling J; Geller C; Klein HU
    Am J Cardiol; 2002 Nov; 90(9):1011-4. PubMed ID: 12398975
    [No Abstract]   [Full Text] [Related]  

  • 31. Atrial fibrillatory rate and risk of left atrial thrombus in atrial fibrillation.
    Bollmann A; Husser D; Stridh M; Holmqvist F; Roijer A; Meurling CJ; Sörnmo L; Olsson SB
    Europace; 2007 Aug; 9(8):621-6. PubMed ID: 17604306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abrupt changes in fibrillatory wave characteristics at the termination of paroxysmal atrial fibrillation in humans.
    Petrutiu S; Sahakian AV; Swiryn S
    Europace; 2007 Jul; 9(7):466-70. PubMed ID: 17540663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
    Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive assessment of the atrial cycle length during atrial fibrillation in man: introducing, validating and illustrating a new ECG method.
    Holm M; Pehrson S; Ingemansson M; Sörnmo L; Johansson R; Sandhall L; Sunemark M; Smideberg B; Olsson C; Olsson SB
    Cardiovasc Res; 1998 Apr; 38(1):69-81. PubMed ID: 9683908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between pattern of occurrence of atrial fibrillation and surface electrocardiographic fibrillatory wave characteristics.
    Xi Q; Sahakian AV; Frohlich TG; Ng J; Swiryn S
    Heart Rhythm; 2004 Dec; 1(6):656-63. PubMed ID: 15851236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The electrocardiogram as a predictor of successful pharmacological cardioversion and progression of atrial fibrillation.
    Zeemering S; Lankveld TAR; Bonizzi P; Limantoro I; Bekkers SCAM; Crijns HJGM; Schotten U
    Europace; 2018 Jul; 20(7):e96-e104. PubMed ID: 29016756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VERDICT: the Verapamil versus Digoxin Cardioversion Trial: A randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation.
    Van Noord T; Van Gelder IC; Tieleman RG; Bosker HA; Tuinenburg AE; Volkers C; Veeger NJ; Crijns HJ
    J Cardiovasc Electrophysiol; 2001 Jul; 12(7):766-9. PubMed ID: 11469424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface ECG and intracardiac spectral measures predict atrial fibrillation recurrence after catheter ablation.
    Szilágyi J; Walters TE; Marcus GM; Vedantham V; Moss JD; Badhwar N; Lee B; Lee R; Tseng ZH; Gerstenfeld EP
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1371-1378. PubMed ID: 30016007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
    Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrocardiographic characteristics of fibrillatory waves in new-onset atrial fibrillation.
    Husser D; Cannom DS; Bhandari AK; Stridh M; Sörnmo L; Olsson SB; Bollmann A
    Europace; 2007 Aug; 9(8):638-42. PubMed ID: 17470676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.